Brexit

The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?
The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?
Pharmaforum
Brexit
UK
Europe
Flag link:
What does Brexit mean for biopharma companies?
What does Brexit mean for biopharma companies?
Biopharma Reporter
Brexit
UK
Europe
patents
Flag link:
Brexit could hinder access to coronavirus vaccines, says pharma group
Brexit could hinder access to coronavirus vaccines, says pharma group
Pharmaforum
UK
Brexit
COVID-19
vaccines
pandemic
Flag link:
Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile
Fearing Brexit chaos, UK asks pharma to build six-week drug stockpile
Pharmaforum
UK
Brexit
drug shortages
Flag link:
Biopharma industry urges MRA to mitigate risk of no-deal Brexit
Biopharma industry urges MRA to mitigate risk of no-deal Brexit
RAPS.org
UK
Europe
Brexit
MRA
EFPIA
Flag link:
Brexit drug stock piles ‘used up’ during coronavirus pandemic
Brexit drug stock piles ‘used up’ during coronavirus pandemic
Pharmaforum
UK
Brexit
COVID-19
Flag link:
Dutch biotech sector feel benefits of EMA move, says industry leader
Dutch biotech sector feel benefits of EMA move, says industry leader
Pharmaforum
EMA
Europe
The Netherlands
Brexit
biotech
Flag link:
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Amid U.K. cutbacks, AstraZeneca plows $520M into manufacturing and R&D in France
Fierce Pharma
AstraZeneca
R&D
France
Brexit
UK
drug manufacturing
Flag link:
Biopharma Execs Remain Optimistic Despite Political Headwinds
Biopharma Execs Remain Optimistic Despite Political Headwinds
Xconomy
drug pricing
regulatory
Brexit
political
Flag link:
Audit body warns of risks to medicine supplies in no-deal Brexit, despite preparations
Audit body warns of risks to medicine supplies in no-deal Brexit, despite preparations
Pharmaforum
Brexit
UK
Flag link:
Factbox: Britain's insulin providers prepare for Brexit fallout
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Novo Nordisk
Eli Lilly
Sanofi
UK
Brexit
insulin
diabetes
Flag link:
As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit
As Brexit nears, Britain's drugs, devices and pricing regulators seek the exit
Fierce Biotech
Brexit
UK
devices
drug pricing
Flag link:
Brexit's Disruptive Impact On U.K. And European Prescription Drug Market
Brexit's Disruptive Impact On U.K. And European Prescription Drug Market
Forbes
Brexit
UK
Europe
Flag link:
Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning
Science sector lauds UK’s visa scheme, but repeats no-deal Brexit warning
Pharmaforum
UK
Brexit
visas
Flag link:
Nine for 2019: Challenges impacting pharma
Nine for 2019: Challenges impacting pharma
Pharmaforum
global pharma
R&D
M&A
Brexit
Flag link:
BI chief “regrets” Brexit, but continues to invest in UK
BI chief “regrets” Brexit, but continues to invest in UK
Pharmaforum
UK
Brexit
Boehringer Ingelheim
Flag link:
UK R&D Roundup: Pharma gets in on the biotech boom
UK R&D Roundup: Pharma gets in on the biotech boom
Pharmaforum
UK
Brexit
biotech
R&D
Flag link:
As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?
As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?
Pharmaforum
Brexit
UK
Europe
Flag link:
Sanofi may airlift medicines into UK after Brexit
Sanofi may airlift medicines into UK after Brexit
Pharmaforum
Sanofi
UK
Europe
Brexit
vaccines
flu vaccines
Flag link:
Brexit delay offers biopharma more time to prepare for a no-deal
Brexit delay offers biopharma more time to prepare for a no-deal
BioCentury
Europe
UK
Brexit
drug shortages
Flag link:

Pages